A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This study will test whether treatment with erlotinib plus SU011248 is better than erlotinib
alone in patients with advanced/metastatic lung cancer who have received previous treatment
with a platinum-based regimen.